Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Annals of Surgical Oncology|March 31, 2020
Predictors of Disease Progression or Performance Status Decline in Patients Undergoing Neoadjuvant Therapy for Localized Pancreatic Head AdenocarcinomaAlessandro Paniccia, Ana L Gleisner, Mazen S Zenati, et al.
The Journal of Biological Chemistry|December 1, 2005
A critical role for calponin 2 in vascular developmentJian Tang, Guang Hu, Jun-ichi Hanai, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|February 22, 2023
No survival benefit with suboptimal CA19-9 response: defining effective neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancerHao Liu, Mark D'Alesio, Samer AlMasri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2023
Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell InfiltrationGregory L Beatty, Devora Delman, Jiayi Yu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 7, 2017
Identification of Targetable ALK Rearrangements in Pancreatic Ductal AdenocarcinomaAatur D Singhi, Siraj M Ali, Jill Lacy, et al.
Clinical Colorectal Cancer|August 5, 2011
Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancerBenedito A Carneiro, Ramesh K Ramanathan, Marwan G Fakih, et al.
Annals of Surgical Oncology|December 21, 2016
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal MetastasesMashaal Dhir, Lekshmi Ramalingam, Yongli Shuai, et al.
Annals of Surgical Oncology|April 24, 2015
Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic AdenocarcinomaBrian A Boone, Nathan Bahary, Amer H Zureikat, et al.
Pageof 13